İrena Butrimienė - Concepedia

Author

İrena Butrimienė

Also Known As

Butrimiene Irena, Butrimiene, I, Butrimiene, I., I Butrimiene, I. Butrimiene, I. Butrimienė, Irena Butrimiene, Irena Butrimienė, İrena Butrimienė

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

Vilnius University State Research Institute Centre for Innovative Medicine National Cancer Institute Istituti di Ricovero e Cura a Carattere Scientifico Carol Davila University of Medicine and Pharmacy

İB

About

İrena Butrimienė is an author at Vilnius University specializing in medicine, autoimmune disease, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	774
2	Immunology	3	3	658
3	Epidemiology	2	2	60
4	Public Health	1	1	41
5	Social Sciences	1	1	19

İrena Butrimienė

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial Dinesh Khanna, Celia J. F. Lin, Daniel E. Furst, The Lancet Respiratory Medicine Autoimmune DiseaseSystemic SclerodermaImmunologySystemic SclerosisMultiple Sclerosis	2020	612
Eprodisate for the Treatment of Renal Disease in AA Amyloidosis Laura M. Dember, Philip N. Hawkins, Bouke P. C. Hazenberg, New England Journal of Medicine	2007	271
Three month treatment of reactive arthritis with azithromycin: a EULAR double blind, placebo controlled study Tore K Kvien, J. S. Hill Gaston, Thomas Bardin, Annals of the Rheumatic Diseases	2004	106
Vitamin D and VDR Gene Polymorphisms’ Association with Rheumatoid Arthritis in Lithuanian Population Eglė Puncevičienė, J. Gaizevska, Rasa Sabaliauskaitė, Medicina	2021	97
Different cytokine profiles in patients with chronic and acute reactive arthritis İrena Butrimienė British journal of rheumatology	2004	51
Distribution of Peripheral Lymphocyte Populations in Primary Sjögren’s Syndrome Patients Gintaras Sudzius, Diana Mieliauskaitė, Almantas Šiaurys, Journal of Immunology Research	2015	45
Diagnostic performance of amyloid A protein quantification in fat tissue of patients with clinical AA amyloidosis Bouke P. C. Hazenberg, Johan Bijzet, Pieter C. Limburg, Amyloid	2007	42
Validity of the rheumatoid arthritis impact of disease (RAID) score and definition of cut-off points for disease activity states in a population-based European cohort of patients with rheumatoid arthritis Fausto Salaffi, Marco Di Carlo, Jelena Vojinović, Joint Bone Spine Rheumatoid DisorderRheumatologyEpidemiologyRheumatic DiseasesClinical Epidemiology	2017	41
Influence of Immunogenicity on the Efficacy of Long-Term Treatment with TNF<i>α</i>Blockers in Rheumatoid Arthritis and Spondyloarthritis Patients Inesa Arštikytė, Giedrė Kaplerytė, İrena Butrimienė, BioMed Research International	2015	33
Efficacy and Safety of Tocilizumab for the Treatment of Systemic Sclerosis: Results from a Phase 3 Randomized Controlled Trial Dinesh Khanna, Celia J. F. Lin, Masataka Kuwana, Arthritis & Rheumatism Autoimmune DiseaseSystemic SclerodermaSystemic TreatmentImmunologyClinical Trials	2018	33

Page 1